Biotage Ab Profile

Performance

   

Odds of Distress

Check how we calculate scores
Equity ratings for Biotage Ab Ord A are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting July 22, 2019 and ending today October 20, 2019. Click here to learn more.

Biotage Ab Profile

Biotage AB , a life science company, provides solutions, knowledge, and experience in the areas of organic and analytical chemistry, as well as for industrial applications in the United States, Europe, Japan, China, and internationally. The company sells its products to pharmaceutical and biotechnical companies, contract research and manufacturing organizations, and academic institutions and commercial, hospitalbio-analytical, and forensic laboratories, as well as laboratories within food and environmental analysis. Biotage Ab is traded on BATS Exchange in USA. more
NameBiotage Ab Ord A
President and CEOTorben JoergensenView All
Macroaxis Advice
InstrumentUSA OTC Stock View All
Business AddressBox 8
ExchangeBATS Exchange
BenchmarkDOW
Websitewww.biotage.com
Phone46 18 56 59 00
CurrencyUSD - US Dollar
Next Fiscal Year EndDecember 31, 2020
Most Recent QuarterJune 30, 2019
Last Fiscal Year EndDecember 31, 2018
Biotage Ab Ord A [BITGF] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Small-Cap' category with current market capitalization of 705.2 M. Biotage Ab Ord has 64.71 M outstanding shares. BIOTAGE AB has accumulated about 15.1 M in cash with 19.09 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.23.
Check Biotage Ab Probability Of Bankruptcy

Biotage Ab Target Price Odds Analysis

Odds Below 10.7HorizonTargetOdds Above 10.7
29.92%30 days 10.70 69.83%
Based on normal probability distribution, the odds of Biotage Ab to move above current price in 30 days from now is about 69.83 (This Biotage Ab Ord A probability density function shows the probability of Biotage Ab OTC Stock to fall within a particular range of prices over 30 days) .

Biotage Ab Ord Risk Profiles

Biotage Ab Key Fundamentals

Biotage Ab Against Markets

Did you try this?

Run Competition Analyzer Now

   

Competition Analyzer

Analyze and compare many basic indicators for a group of related or unrelated entities
All  Next Launch Module

Biotage Ab Corporate Directors

Karolina Lawitz Member of the Board of Directors
NilsOlof Bjork Director
Yvonne Martensson Director
Check also Trending Equities. Please also try Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Search macroaxis.com